Metraipolis › archive › dc_df5a2f25fb06

Topical Losartan in Ophthalmology: Rationale, Experimental and Clinical Evidence, and Emerging Clinical Applications — Europe PMC PMID:41753041

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41753041
DOI
10.3390/jcm15041354
License (as archived)
solo-consultazione
Archived
2026-11-06T00:32:22.701Z
SHA-256 of the archived text
bf68c2769d51683954741726c4f70667a225db9d22b8d2108dc7e3afe6d523df
Stable URL of this page
https://metraipolis.com/documento/dc_df5a2f25fb06

How to cite

Topical Losartan in Ophthalmology: Rationale, Experimental and Clinical Evidence, and Emerging Clinical Applications — Europe PMC PMID:41753041 — Europe PMC (en), https://europepmc.org/article/MED/41753041 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_df5a2f25fb06 (Metraipolis archive dc_df5a2f25fb06, sha256 bf68c2769d51683954741726c4f70667a225db9d22b8d2108dc7e3afe6d523df)
BibTeX
@misc{dcdf5a2f25fb06,
  title = {Topical Losartan in Ophthalmology: Rationale, Experimental and Clinical Evidence, and Emerging Clinical Applications — Europe PMC PMID:41753041},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41753041},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_df5a2f25fb06; sha256 bf68c2769d51683954741726c4f70667a225db9d22b8d2108dc7e3afe6d523df},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41753041. Agents can read the archived copy with the MCP tool read_document.